SOW
XERS icon

State of Wyoming’s Xeris Biopharma Holdings XERS Stock Holding History

State of Wyoming’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.4K Sell
10,420
-32,038
-75% -$212K 0.01% 1489
2025
Q4 		$333K Buy
42,458
+29,558
+229% +$233K 0.04% 647
2025
Q3 		$105K Sell
12,900
-22,306
-63% -$148K 0.01% 1293
2025
Q2 		$164K Buy
+35,206
New +$161K 0.02% 1044
2022
Q2 		– Sell
-19,836
Closed -$51K – 2167
2022
Q1 		$51K Buy
19,836
+12,125
+157% +$29.6K 0.03% 1050
2021
Q4 		$23K Buy
+7,711
New +$16.7K 0.01% 1433

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State of Wyoming's XERS Position: Q1 2026 in Review

State of Wyoming reduced its Xeris Biopharma Holdings (XERS) stake by 75% in Q1 2026, selling an estimated $212K and leaving 10,420 shares worth $60.4K. The position accounts for 0.01% of the portfolio, ranked #1489.

State of Wyoming first reported a position in XERS in Q4 2021 and has held it in 6 quarters since. The position peaked at $333K in Q4 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • State of Wyoming held 10,420 shares of Xeris Biopharma Holdings worth $60.4K as of Q1 2026.
  • State of Wyoming sold 32,038 Xeris Biopharma Holdings shares in Q1 2026, an estimated $212K.
  • Xeris Biopharma Holdings made up 0.01% of State of Wyoming's portfolio in Q1 2026, its #1489 holding.
  • State of Wyoming first reported a position in Xeris Biopharma Holdings in Q4 2021 and has held it in 6 quarters since.
  • State of Wyoming's Xeris Biopharma Holdings position peaked at $333K in Q4 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.